Myocardial ketone body oxidation underlies the salutary effects of SGLT2 inhibitor treatment in heart failure

21 May 2023 (11:17 - 12:25)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 3 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by